| Company Name: |
Hangzhou Peptidego Biotech Co.,Ltd.
|
| Tel: |
0571-87213919 |
| Email: |
Eric@peptidego.com |
| Products Intro: |
Product Name:Myhc-α(334–352)
CAS:171675-09-5
Purity:95% or 98% HPLC Package:1mg；5mg；10mg；50mg；100mg,1g or according to customer's detail requirement.
|
| Company Name: |
Nanjing Yuanpeptide Biotech Co.，Ltd.
|
| Tel: |
18168071971 |
| Email: |
support@yuan-peptide.com |
| Products Intro: |
Product Name:Myhc-α(334–352)
CAS:171675-09-5
Purity:>=95% or98% Package:1mg\g\kg;1mg\g\kg;1mg\g\kg
|
| Company Name: |
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
|
| Tel: |
0571-87213919 17306812703 |
| Email: |
3007955328@qq.com |
| Products Intro: |
Product Name:Myhc-α(334–352)
CAS:171675-09-5
Purity:95% or 98% HPLC Package:1mg；5mg；10mg；50mg；100mg,1g or according to customer's detail requirement.
|
|
| | L-Lysine, L-α-aspartyl-L-seryl-L-alanyl-L-phenylalanyl-L-α-aspartyl-L-valyl-L-leucyl-L-seryl-L-phenylalanyl-L-threonyl-L-alanyl-L-α-glutamyl-L-α-glutamyl-L-lysyl-L-alanylglycyl-L-valyl-L-tyrosyl- Basic information |
| | L-Lysine, L-α-aspartyl-L-seryl-L-alanyl-L-phenylalanyl-L-α-aspartyl-L-valyl-L-leucyl-L-seryl-L-phenylalanyl-L-threonyl-L-alanyl-L-α-glutamyl-L-α-glutamyl-L-lysyl-L-alanylglycyl-L-valyl-L-tyrosyl- Chemical Properties |
| Boiling point | 2259.2±65.0 °C(Predicted) | | density | 1.335±0.06 g/cm3(Predicted) | | pka | 3.27±0.10(Predicted) | | form | Solid | | color | White to off-white | | Sequence | Asp-Ser-Ala-Phe-Asp-Val-Leu-Ser-Phe-Thr-Ala-Glu-Glu-Lys-Ala-Gly-Val-Tyr-Lys |
| | L-Lysine, L-α-aspartyl-L-seryl-L-alanyl-L-phenylalanyl-L-α-aspartyl-L-valyl-L-leucyl-L-seryl-L-phenylalanyl-L-threonyl-L-alanyl-L-α-glutamyl-L-α-glutamyl-L-lysyl-L-alanylglycyl-L-valyl-L-tyrosyl- Usage And Synthesis |
| Uses | Myhc-α(334–352) is a sequence fragment of amino acid residues 334 to 352 of cardiac myosin heavy chain α. Myhc-α(334–352) is an immunodominant epitope that can induce autoimmune reactions in A/J mice, leading to the occurrence of myocarditis. Myhc-α(334–352) can be used to study the autoimmune pathways of myocarditis and dilated cardiomyopathy[1]. | | References | [1] Massilamany C, et al. Identification of novel mimicry epitopes for cardiac myosin heavy chain-α that induce autoimmune myocarditis in A/J mice[J]. Cellular immunology, 2011, 271(2): 438-449. DOI:10.1016/j.cellimm.2011.08.013 |
| | L-Lysine, L-α-aspartyl-L-seryl-L-alanyl-L-phenylalanyl-L-α-aspartyl-L-valyl-L-leucyl-L-seryl-L-phenylalanyl-L-threonyl-L-alanyl-L-α-glutamyl-L-α-glutamyl-L-lysyl-L-alanylglycyl-L-valyl-L-tyrosyl- Preparation Products And Raw materials |
|